EDWARDS JEFFREY L

CIK 00011906425 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001190642

Recent Transactions

50 trades

Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2025-06-04+120,000→ 120,000 total
Award
BIO-RAD LABORATORIES, INC.$BIO
Restricted Stock Units
2025-04-22+407→ 407 total
Exercise/Conversion
BIO-RAD LABORATORIES, INC.$BIO
Bio-Rad A Common Stock
2025-04-22+308→ 308 total
Exercise/Conversion
BIO-RAD LABORATORIES, INC.$BIO
Restricted Stock Units
2025-04-22−308→ 0 total
Award
BIO-RAD LABORATORIES, INC.$BIO
Restricted Stock Units
2024-09-06+308→ 308 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2024-07-08+30,000→ 79,667 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2024-06-20+45,000→ 45,000 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2024-06-05+70,000→ 70,000 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2024-02-01+9,554→ 49,667 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2024-02-01−9,554→ 0 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2023-06-22+30,000→ 30,000 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-09$16.74/sh−3,265→ 38,601 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-09$17.51/sh−4,624→ 33,977 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-06-07+8,289→ 41,866 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-06-07+12,666→ 12,666 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2023-06-01+18,182→ 40,113 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2023-05-31+9,474→ 21,931 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2023-05-31−9,474→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2023-02-01+9,554→ 9,554 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2022-06-22+30,000→ 30,000 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2022-06-16+25,684→ 25,684 total
Award
FIBROGEN INC$FGEN
Common Stock
2022-06-16+15,777→ 33,577 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-06-04$9.50/sh−7,059→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2022-06-04$9.50/sh+7,059→ 12,457 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-05-31+9,474→ 9,474 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2021-10-14$9.77/sh+5,398→ 5,398 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-10-14$9.77/sh−5,398→ 0 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2021-06-10+25,000→ 25,000 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-06-04+7,059→ 7,059 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2021-05-26+7,800→ 7,800 total
Award
FIBROGEN INC$FGEN
Common Stock
2021-05-26+4,700→ 17,800 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2020-10-14+5,398→ 5,398 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2020-06-18+25,000→ 25,000 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2020-06-04+7,800→ 7,800 total
Award
FIBROGEN INC$FGEN
Common Stock
2020-06-04+4,700→ 13,100 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2019-06-20+20,000→ 20,000 total
Award
FIBROGEN INC$FGEN
Common Stock
2019-06-05+4,700→ 8,400 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2019-06-05+7,800→ 7,800 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2018-09-26+22,500→ 22,500 total
Award
FIBROGEN INC$FGEN
Common Stock
2018-06-05+3,700→ 3,700 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2018-06-05+6,000→ 6,000 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2017-06-07+12,000→ 12,000 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2016-06-08+12,000→ 12,000 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2015-10-28+7,168→ 7,168 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2015-10-28+12,000→ 12,000 total
Award
ALLERGAN INC
Employee Stock Option (Right to Buy)
2014-02-21$125.07/sh+58,815→ 58,815 total
Sale
ALLERGAN INC
Common Stock
2014-02-19$126.39/sh−38,900→ 16,591 total
Exercise/Conversion
ALLERGAN INC
Employee Stock Option (Right to Buy)
2014-02-19−38,900→ 0 total
Exercise/Conversion
ALLERGAN INC
Common Stock
2014-02-19$40.16/sh+38,900→ 55,491 total
Tax Payment
ALLERGAN INC
Common Stock
2014-02-14$124.57/sh−280→ 16,591 total

Companies

Recent Filings

Address

2525 DUPONT DRIVE

IRVINE, CA, 92612

View on SEC.gov